More Healios Kk news
Healios KkTSE: 4593

Healios Selected for the AMED “Project to Promote the Industrialization of Regenerative/Cell Medicine and Gene Therapy”

Jul 27, 2026 at 2:45 AM UTC · Issued by Healios Kk via TDnet

Healios Kk (4593) Press Release

View Attachment

Company analysis

Earlier from Healios Kk

  • Notice Regarding the Filing of a Counterclaim in Response to a Lawsuit Filed Against HealiosJun 9
  • Healios K.K. to Present at Jefferies Global Healthcare ConferenceNov 11, 2025
  • Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines ConferenceOct 20, 2025
  • Healios K.K. to Present at the 2025 Jefferies Global Healthcare ConferenceMay 28, 2025
All Healios Kk news releases↗